Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Psyched Wellness (PSYC) announced that it’s proprietary Amanita Muscaria Extract (AME-1) is now available for preorder in the U.S.
  • Calm, facilitates rest within the body and mind, and does not require a prescription
  • Psyched has approval to sell in the United States via Self-GRAS (Generally Regarded as Safe) designation
  • The company plans to submit the application for AME-1 as an NDI (a New Dietary Ingredient) to the FDA this fall
  • Psyched Wellness Ltd. is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products
  • Psyched Wellness Ltd. (PSYC) opened trading at C$0.13

Psyched Wellness (PSYC) announced that it’s proprietary Amanita Muscaria Extract (AME-1) is now available for preorder in the U.S.

Consumers can now purchase a safe and legal mushroom extract that has been used for thousands of years for its healing properties.

Psyched has approval to sell in the United States via Self-GRAS (Generally Regarded as Safe) designation, which allows the company to sell its AME-1 products. The company plans to submit the application for AME-1 as an NDI (a New Dietary Ingredient) to the FDA this fall.

The product, called Calm, facilitates rest within the body and mind, and does not require a prescription. This leaves the retail landscape open to many possibilities for distribution and listing potential.

Chief Commercial Officer, Matthew Singh, commented on the news.

“Our entire team is excited to take this step into full-scale commercialization. We begin with the launch of Calm, then follow with additional SKUs and product innovation. Our presale initiative will build a sales pipeline and [hopefully] attract the attention of all individuals with an interest in this sector. We firmly believe our product offerings will separate us from the pack when compared to any other mushroom company on the market today. Try Calm, the very first legal Amanita Muscaria product for sale in the United States, and discover what separates Psyched Wellness from all other companies working within our discipline.”

Psyched Wellness is a health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods.

Psyched Wellness Ltd. (PSYC) opened trading at C$0.13. 

More From The Market Herald

" Field Trip Health & Wellness (TSXV:FTHW) begins trading on the OTC Market

Field Trip Health & Wellness (FTHW) has received approval to start trading on the OTCQB Market in the United States.

" Revive Therapeutics (CSE:RVV) & PharmaTher (CSE:PHRM) sign MDMA research collaboration agreement

Revive Therapeutics (RVV), and PharmaTher (PHRM) have signed a research collaboration agreement.

" Numinus (TSX:NUMI) receives Health Canada approval for psychedelic tea therapy

Numinus Wellness (NUMI) has received approval from Health Canada for its experiential training study.